|Articles|August 20, 2019

Prospectus For Establishment of a DSCSA Governance Body

Click on the link below to read the document:

Final Governance Prospectus Document_080919

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe

Related Content

Kala Shankle on What Comes Next for National Licensure

ByKala Shankle, JD,Stephen Appezzato

September 10th 2026

Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

ByStephen Appezzato

September 10th 2026

Pills stacked against money background, toned in blue | © Enso - stock.adobe.com 343271169

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

ByStephen Appezzato

September 9th 2026

Why the Biggest NDC-12 Risk Sits in the Handoffs

ByLiberty Dewey,Stephen Appezzato

September 9th 2026

Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.

The Transition to Home: Why Confidence is Critical to Patient Success

ByJoe Reynolds, Noble

September 9th 2026

Prospectus For Establishment of a DSCSA Governance Body

Related Content

Kala Shankle on What Comes Next for National Licensure

Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

Why the Biggest NDC-12 Risk Sits in the Handoffs

The Transition to Home: Why Confidence is Critical to Patient Success

Trending on Pharmaceutical Commerce

FAQ: Inside the Latest MFN Deals Signed by Nine Drugmakers

Pharma Pulse: DHL's New Singapore Hub and Pharma Rethinks Go-To Market

Why the Biggest NDC-12 Risk Sits in the Handoffs

How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain

The Proprietary LLM Behind ClaimGuardRx's Detect-and-Respond Engine